U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885905) titled 'Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being' on March 13.
Brief Summary: To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Study Start Date: Nov. 27, 2024
Study Type: OBSERVATIONAL
Condition:
Chronic Pulmonary Aspergillosis
Recruitment Status: RECRUITING
Sponsor: Imperial College London
Disclaimer: Curated by HT Syndication....